High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag | Aplastic Anemia & MDS International Foundation

High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag

Journal Title: 
Leukemia
Primary Author: 
Kohei Hosokawa
Author(s): 
Kohei Hosokawa, Hirohito Yamazaki, Mikoto Tanabe, Tatsuya Imi, Naomi Sugimori, Shinji Nakao
Original Publication Date: 
Friday, July 3, 2020
Bone Marrow Diseases: